LONDON, Aug. 11, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company"), a market-leading medical technology and innovation company, today announced that André-Michel Ballester, Chief Executive Officer of LivaNova, and Vivid Sehgal, Chief Financial Officer of LivaNova, will both be participating in a discussion at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016.
The discussion is scheduled to begin at 11:40 a.m. Eastern Daylight Time on Monday, September 12, 2016. It will be available to all interested parties through a live audiocast accessible via the investor relations section of LivaNova's website at www.livanova.com (http://www.livanova.com/). Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. A replay of the webcast will be available on the LivaNova website approximately 24 hours after the live presentation for 90 days after the event.
About LivaNova
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems.
The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K.
| For more information, please visit www.livanova.com (http://www.livanova.com/), or contact: Investor Relations and Media Karen King Vice President, Investor Relations & Corporate Communications Phone: +1 (281) 228-7262 Fax: +1 (281) 218-9332 e-mail: corporate.communications@livanova.com (http://www.globenewswire.com/Tracker?data=QzzQmLHW-C4MKgMXvOb3lpyUROKQhvmzsMbfsw_-ttJJ-GOzJ8zqNR6g1wGDnaW6J0cq6gLcoc_PdQrR7xSE2GF-uNnJhD5botPjJ45qi4Sh9d1_PylORpJSyV_9TAm6SmChJ4n4RcZ1iMcrYrt9rw==) |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: LivaNova PLC via Globenewswire
